HHMI Bets Big On 19 New Investigators
CHEVY CHASE, Md., May 23, 2018 /PRNewswire-USNewswire/ -- Beth Shapiro has dug for prehistoric bones in Siberia. Ralph DeBerardinis has improved the lives of kids with metabolic diseases. Jesse Bloom has uncovered genetic secrets that could help fight the flu.
Shapiro, DeBerardinis, and Bloom are among 19 scientists whose work is dramatically advancing our understanding of cells, the brain, metabolism, and more. Today, these scientists all share a new title: Howard Hughes Medical Institute (HHMI) Investigator.
On May 23, 2018, HHMI announced that it will invest $200 million in this new cadre of investigators, a group of individuals known for pushing the boundaries of biomedical research. "We selected these scientists because they know how to ask hard and interesting questions with skill and intellectual courage," says David Clapham, HHMI's vice president and chief scientific officer. "We believe they have the potential to make breakthroughs over time."
Each of the 19 new investigators will receive roughly $8 million over a seven-year term, which is renewable pending a scientific review. In addition, investigator support includes a guaranteed two-year transition period. This new group of investigators is the first to be appointed to a seven-year term (previous terms lasted five years). HHMI selected the new investigators from a pool of 675 eligible applicants. The scientists represent 15 U.S. institutions and will join an investigator community that now numbers over 300.
"Every scientist is unique, but they all need one thing: time," says HHMI President Erin O'Shea. "HHMI is dedicated to providing outstanding biomedical scientists with the time and resources to do their best work. We think of this as investing in people, not just projects."
To date, 28 current or former HHMI scientists have won the Nobel Prize. Investigators have made big leaps forward in HIV vaccine development, microbiome and circadian rhythm research, immunotherapy, and the genome editing tool known as CRISPR/Cas9, among other fields.
2018 HHMI Investigators
| Name |
Institute |
| Thomas Bernhardt, PhD |
Harvard Medical School |
| Jesse Bloom, PhD |
Fred Hutchinson Cancer Research Center |
| Edward Boyden, PhD |
Massachusetts Institute of Technology |
| Clifford Brangwynne, PhD |
Princeton University |
| Howard Chang, MD, PhD |
Stanford University |
| Ralph DeBerardinis, MD, PhD |
University of Texas Southwestern Medical Center |
| Benjamin Ebert, MD, PhD |
Dana-Farber Cancer Institute |
| Zachary Knight, PhD |
University of California, San Francisco |
| Stephen Liberles, PhD |
Harvard Medical School |
| Zachary Lippman, PhD |
Cold Spring Harbor Laboratory |
| Gaby Maimon, PhD |
The Rockefeller University |
| Luciano Marraffini, PhD |
The Rockefeller University |
| Samara Reck-Peterson, PhD |
University of California, San Diego |
| Elizabeth Sattely, PhD |
Stanford University |
| Beth Shapiro, DPhil |
University of California, Santa Cruz |
| Beth Stevens, PhD |
Boston Children's Hospital |
| Gia Voeltz, PhD |
University of Colorado Boulder |
| Meng Wang, PhD |
Baylor College of Medicine |
| Feng Zhang, PhD |
Massachusetts Institute of Technology |
The Howard Hughes Medical Institute plays an important role in advancing scientific research and education in the United States. Its scientists, located across the country and around the world, have made important discoveries that advance both human health and our fundamental understanding of biology. The Institute also aims to transform science education into a creative, interdisciplinary endeavor that reflects the excitement of real research. HHMI's headquarters are located in Chevy Chase, Maryland, just outside Washington, D.C.
Media Contacts: Meghan Rosen
Media Relations Manager
[email protected]
Phone: 301-215-8859
This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.
SOURCE Howard Hughes Medical Institute
Share this article